Live Breaking News & Updates on Biancam Nagata

Stay updated with breaking news from Biancam nagata. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Duke University: New Vaccine Blocks COVID-19 and Variants, Plus Other Coronaviruses


Share
A potential new vaccine developed by members of the Duke Human Vaccine Institute has proven effective in protecting monkeys and mice from a variety of coronavirus infections including SARS-CoV-2 as well as the original SARS-CoV-1 and related bat coronaviruses that could potentially cause the next pandemic.
The new vaccine, called a pan-coronavirus vaccine, triggers neutralizing antibodies via a nanoparticle. The nanoparticle is composed of the coronavirus part that allows it to bind to the body’s cell receptors, and is formulated with a chemical booster called an adjuvant. Success in primates is highly relevant to humans.
The findings appear Monday, May 10 in the journal Nature. ....

South Africa , United Kingdom , Rachell Spreng , C Todd Demarco , Mahnaz Minai , Surender Khurana , Thomash Oguin , Kartik Manne , Sophie Gobeil , Elizabethw Petzold , S Munir Alam , Matthew Gagne , Markg Lewis , Diann Moore , Hanne Andersen , Fangping Cai , Kevin Saunders , Davidr Martinez , Longpingv Tse , Robertj Edwards , Laural Sutherland , Christopherb Fox , Gregoryd Sempowski , Kevin Wiehe , R Wes Rountree , Maggie Barr ,

Duke scientists develop new potential coronavirus vaccine – it's already effective in animal studies


by Sarah Avery May 10, 2021 .
DURHAM – A potential new vaccine developed by members of the Duke Human Vaccine Institute has proven effective in protecting monkeys and mice from a variety of coronavirus infections – including SARS-CoV-2 as well as the original SARS-CoV-1 and related bat coronaviruses that could potentially cause the next pandemic.
The new vaccine, called a pan-coronavirus vaccine, triggers neutralizing antibodies via a nanoparticle. The nanoparticle is composed of the coronavirus part that allows it to bind to the body’s cell receptors, and is formulated with a chemical booster called an adjuvant. Success in primates is highly relevant to humans. ....

South Africa , State Of North Carolina , North Carolina , United States , United Kingdom , University Of North Carolina , Rachell Spreng , C Todd Demarco , Mahnaz Minai , Surender Khurana , Thomash Oguin , Kartik Manne , Sophie Gobeil , Elizabethw Petzold , S Munir Alam , Matthew Gagne , Markg Lewis , Diann Moore , Hanne Andersen , Fangping Cai , Kevin Saunders , Davidr Martinez , Longpingv Tse , Robertj Edwards , Laural Sutherland , Christopherb Fox ,

New vaccine blocks COVID-19 and variants, plus other coronaviruses


 E-Mail
DURHAM, N.C. - A potential new vaccine developed by members of the Duke Human Vaccine Institute has proven effective in protecting monkeys and mice from a variety of coronavirus infections including SARS-CoV-2 as well as the original SARS-CoV-1 and related bat coronaviruses that could potentially cause the next pandemic.
The new vaccine, called a pan-coronavirus vaccine, triggers neutralizing antibodies via a nanoparticle. The nanoparticle is composed of the coronavirus part that allows it to bind to the body s cell receptors and is formulated with a chemical booster called an adjuvant. Success in primates is highly relevant to humans. ....

South Africa , State Of North Carolina , North Carolina , United States , United Kingdom , University Of North Carolina , Rachell Spreng , C Todd Demarco , Mahnaz Minai , Surender Khurana , Thomash Oguin , Kartik Manne , Sophie Gobeil , Elizabethw Petzold , S Munir Alam , Matthew Gagne , Markg Lewis , Diann Moore , Hanne Andersen , Fangping Cai , Kevin Saunders , Davidr Martinez , Longpingv Tse , Robertj Edwards , Laural Sutherland , Christopherb Fox ,